BALTIMORE, MD--(MARKET WIRE)--Oct 6, 2008 -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of purchasers of the common stock of Medicis Pharmaceutical Corp. ("Medicis" or the "Company") (MRX - News) during the period between October 30, 2003 and September 24, 2008, inclusive (the "Class Period").

The complaint charges Medicis and certain of its officers and directors with violations under the Securities Exchange Act of 1934. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff no later than December 2, 2008 and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period. You may contact Brower Piven (through hoffman@browerpiven.com or 410/332-0030) to answer any questions you may have in that regard.

The Complaint alleges that on September 24, 2008, Medicis announced that it intends to restate its financial statements for all accounting periods beginning July 1, 2003 and ending June 30, 2008. The complaint also alleges that the Company indicated that investors can no longer rely on these financial statements and that the restatements result from Medicis applying an improper accounting method in determining reserves for sales returns during the Class Period. The complaint further alleges that the release of this information by Medicis caused the value of the Company's stock price to decline significantly.

If you have suffered a net loss for all transactions in Medicis Pharmaceutical Corp. common stock during the Class Period, you may obtain additional information about this lawsuit and your ability to become a lead plaintiff by contacting Brower Piven at www.browerpiven.com, by email at hoffman@browerpiven.com, by calling 410-332-0030, or at Brower Piven, A Professional Corporation, The World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525, Baltimore, Maryland 21202. Attorneys at Brower Piven have combined experience litigating securities and class action cases of over 40 years. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

     CONTACT:
     Charles J. Piven
     Brower Piven, A Professional Corporation
     Baltimore, Maryland
     410/332-0030
     Email Contact